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Abstract
Orofacial clefts (OFC; MIM 119530) are among the most common major birth defects. Here, we carried out mutation
screening of the PVR and PVRL2 genes, which are both located at an OFC linkage region at 19q13 (OFC3) and are
closely related to PVRL1, which has been associated with both syndromic and non-syndromic cleft lip and palate
(nsCLP). We screened a total of 73 nsCLP patients and 105 non-cleft controls from the USA for variants in PVR and
PVRL2, including all exons and encompassing all isoforms. We identified four variants in PVR and five in PVRL2.
One non-synonymous PVR variant, A67T, was more frequent among nsCLP patients than among normal controls,
but this difference did not achieve statistical significance.
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Orofacial clefts (OFC) are common birth defects, oc-
curringinapproximately1per800NorthAmericanCauca-
sian infants and varying in incidence among patients of
different geographical origins (Vanderas, 1987). Most
cases of OFC (70%) occur sporadically, and may include
isolated cleft lip, cleft lip with or without palate (CLP) and
isolated cleft palate. Such ‘non-syndromic’ OFC appear to
be polygenic in origin, a number of loci each exerting a rel-
atively modest effect against a multi-factorial background
(Spritz, 2001; Murray, 2002; Cobourne, 2004).
A role for one or more genes at chromosome 19q in-
volved in non-syndromic CLP (nsCLP) has been sup-
ported by multiple lines of evidence. Genetic linkage
studies defined OFC3, a region of genetic linkage to
nsCLP on chromosome 19q13 (Stein et al., 1995;
Warringtonetal.,2006).Initialstudiesofcandidategenes
intheOFC3regionfocusedonBCL3,anumberofgenetic
association studies finding conflicting evidence of associ-
ation with nsCLP in various populations (Stein et al.,
1995; Amos et al., 1996; Maestri et al., 1997; Gaspar et
al., 2002; Blanco et al., 2004). Other genes studied in the
OFC3 region include APOC2 (Marazita et al., 2002),
CLPTM1 (Yoshiura et al.,1998; Turhani et al., 2005;
Warrington et al., 2006), and TOMM40 (Warrington et
al.,2006),eachyielding,atbest,inconsistentevidencefor
involvement in nsCLP.
Recent attention has turned to two other candidate
genes in 19q13, PVR and PVRL2, which are paralogous to
PVRL1, in which homozygous mutations result in a rare
autosomal recessive CLP syndrome, CLPED1 (Suzuki et
al., 2000), and in which variants have been genetically as-
sociated with nsCLP in northern Venezuela (Sözen et al.,
2001) and perhaps other populations (Avila et al., 2006;
Scapoli et al., 2006; Tongkobpetch et al., 2008). PVR,
PVRL1, and PRVL2 respectively encode Necl-5/CD155,
nectin-1 and nectin-2, cell adhesion molecules present at
adherens junctions and other ectoplasmic specializations
at cell-cell contacts (Young et al., 2009), and are widely
expressed during development. Warrington et al. (2006)
reported genetic association of a rare intronic variant in
PVR, C__1828143_10 (rs35385129), with nsCLP in pa-
tients from several different populations, and by direct se-
quencing identified 7 variants in PVR and 16 in PVRL2,
none of which appeared to be causal for nsCLP. A subse-
quent study found marginal association of nsCLP in Ital-
ianpatientswithPVRSNPrs35385129,butnoassociation
with a single intronic PVRL2 SNP analyzed (Pezzetti et
al., 2007).
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Short CommunicationInthepresentstudy,wecarriedoutmutationanalyses
of PVR and PVRL2 in USA Caucasian (CEU) patients with
nsCLP and non-cleft controls. We obtained genomic DNA
samples with informed consent from USA patients with
nsCLP but with no other physical or cognitive abnormali-
ties, and from unaffected controls. We initially screened all
8 exons of PVR and 10 exons of PVRL2 (encompassing all
known mRNA isoforms, except the last 21 nt of PVRL2
exon 1) in 73 unrelated USA CEU nsCLP patients and 105
unrelated USA CEU controls. Subsequently, an additional
28 unrelated USA CEU nsCLP patients were specifically
analyzed for the PVR rs1058402 (A67T) variant. The PVR
and PVRL2 PCR primers used are given in Table 1. PCR
products were screened for variation by simultaneous sin-
gle-stranded conformation polymorphism (SSCP)/hetero-
duplex analysis by electrophoresis in 0.5X MDE gels
(Biowhittaker Molecular Applications) containing 10%
glycerol (Lee et al., 1995), followed by DNA sequence
analysisofthoseampliconsexhibitingaberrantSSCP/hete-
roduplex patterns.
AsshowninTable2,weidentifiedatotaloffourvari-
ants in PVR: rs11540085 (-1C > T), rs1058402 (A67T),
rs203710(I340M),andonenovelvariant,19:49856876G>
A (E404E). Similarly, we identified a total of five variants
in PVRL2: rs41290128 (D496N), rs283814 (P409P) and
three novel variants, 19:50077328G > A (A355T),
19:50081289T > C (F440F) and
19:50073660_50073661insAGG (R461-462ins). Most
variantswereobservedinbothpatientsandcontrols,except
for the rare variant PVR 19:49856876G > A (E404E),
which was observed in only one control, PVRL2
19:50077328G > A (A355T) and 19:50081289T > C
(F440F), which we only observed in one and two patients,
respectively, and 19:50073660_50073661insAGG (R461-
462ins),whichwasobservedintwocontrols.Theallelefre-
quency of the non-synonymous PVR variant, rs1058402
(A67T), in spite of being somewhat greater among nsCLP
patients (0.039) than among controls (0.014), did not
achievestatisticalsignificance(p=0.098).Likewise,geno-
type frequency distribution of the rs1058402 variant was
notsignificantlydifferentbetweennsCLPpatientsandcon-
trols.
The etiology of orofacial clefts is complex, most
likely involving many different genetic and environmental
factors, most of which remain unknown. Genetic associa-
tion and linkage, besides studies, have implicated a region
in chromosome 19q13, termed OFC3. Warrington et al.
(2006) reported genetic association between nsCLP and a
rare intronic variant in PVR, rs35385129, in two distinct
populations, although no association was found in two
other patient groups (Warrington et al., 2006; Pezzetti et
al.,2007).Inspiteofthestatisticallynon-significantresults
here reported, our data suggest that PVR may bear further
investigation.
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Table 1 - Oligonucleotide primers for PCR amplification of the exons of PVR and PVRL2.
Amplicon Primer sequences Amplicon
size (bp)
PVR
Exon 1 5’ AGAGCGACGGGCGCCGGGAA 3’
5’ ACTGCGCGGGGGTCACTCAC 3’
165
Exon 2 5’ TTCTCTTCGGTTCTCCGCAG 3’
5’ CCCCAAAACCCCCTGCTC 3’
388
Exon 3 5’ GCTTTTGTTCCTCTTCCCAG 3’
5’ GCTGACTTGGGCACACTCAC 3’
337
Exon 4 5’ TCTGTATCCATTTCCTGCAG 3’
5’ CCCTGAGACCCAGGACTCAC 3’
158
Exon 5 5’ CACCTTTCTGTCTCTCTCCCAG 3’
5’ CCACCCAGGGAGTTCCTCAC 3’
189
Exon 6 5’ CCTGTTTCCTTCTCTTTCAG 3’
5’ GTAGGTGCTCAATTACGGCA 3’
216
Exon 7 5’ TTCCCCTCCTATTTCCCCAG 3’
5’ AGCTCCAACACTGCACTTAC 3’
72
Exon 8 5’ ATTTGAAAACCCTCTTCTAG 3’
5’ GGTCCAACTCTGGAGGCCCA 3’
158
Amplicon Primer sequences Amplicon
size (bp)
PVRL2
Exon 1 5’ CTACTAAACCGCCCAGCCGA 3’
5’ CGGTTTCCAGGAGCAGCAGC 3’
169
Exon 2 5’ GTGGCCCTGCCTGGAGGTGT 3’
5’ TGACCCGCAAGGGGATGCTC 3’
530
Exon 3 5’ CTCCTCTGCTGAGTGTTTGT 3’
5’ GTAGACAGTGCTTTAGAGAA 3’
437
Exon 4 5’ CTATCTGCTAACTTGTCCAC 3’
5’ TTAGATCCAGGAGTCCAGGC 3’
258
Exon 5 5’ TCTTTAGGGATGAGGCCTGTG 3’
5’ AAGTCCTGAAGGGCAGAACT 3’
290
Exon 6 5’ CCCAGAGCGATCCTCGTGAT 3’
5’ AACCAGTCTGGAACCCTAGG 3’
550
Exon 7 5’ GATGGTCGCTTGGAATAAGG 3’
5’ CTCACCCTACCCCATACTC 3’
295
Exon 8 5’ GTGCCATAACCCCGGAGTCA 3’
5’ GCCAGGCCCCTCCCAGCCCT 3’
205
Exon 9 5’ GGCCTGGCAGGGAGAAGCTG 3’
5’ TTGCCAGGCTTGACCCCTGG 3’
228
Exon 10 5’ AAGAGCAGATTGGTAATCTG 3’
5’ GGCACTAGATCCTTGGCAAG 3’
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